Keybanc Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $48

Keybanc analyst Matthew Mishan maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $47 to $48.

Keybanc analyst Matthew Mishan maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $47 to $48.

Total
0
Shares
Related Posts